Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Michael Krowka

TitleInstructor/Fellow
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. DuBrock HM, Forde K, Krok K, Patel M, Al-Naamani N, Lin G, Oh JK, Fallon MB, Kawut SM, Krowka MJ. Cardiac index and hepatopulmonary syndrome in liver transplantation candidates: The pulmonary vascular complications of liver disease study. Liver Transpl. 2023 05 01; 29(5):467-475. PMID: 36862505.
      View in: PubMed
    2. Krowka MJ, Kamath PS. Portopulmonary hypertension: May we agree to disagree? Liver Transpl. 2023 04 01; 29(4):349-350. PMID: 36724441.
      View in: PubMed
    3. Cox-Flaherty K, Moutchia J, Krowka MJ, Al-Naamani N, Fallon MB, DuBrock H, Forde KA, Krok K, Doyle MF, Kawut SM, Ventetuolo CE. Six-Minute walk distance predicts outcomes in liver transplant candidates. Liver Transpl. 2023 05 01; 29(5):521-530. PMID: 36691988.
      View in: PubMed
    4. DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2022 Oct; 12(4):e12172. PMID: 36540874.
      View in: PubMed
    5. Del Valle KT, Krowka MJ, Heimbach JK, Taner T, DuBrock HM. Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes. Transplant Direct. 2022 Dec; 8(12):e1410. PMID: 36398194.
      View in: PubMed
    6. Cajigas HR, Burger CD, Cartin-Ceba R, DuBrock H, Swanson K, Vargas HE, Keaveny AP, Watt KD, Krowka M. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. Mayo Clin Proc. 2022 12; 97(12):2236-2247. PMID: 36336515.
      View in: PubMed
    7. DuBrock HM, Reddy YN, Durst LA, Schroeder DR, Park G, Cajigas HR, Kane GC, Kushwaha SS, McCully RB, Murphy JG, Anand V, Krowka MJ, Frantz RP. The feasibility and value of assessing patient-reported outcomes in pulmonary arterial hypertension. Pulm Circ. 2022 Oct; 12(4):e12143. PMID: 36262468.
      View in: PubMed
    8. Kawut SM, Krowka MJ, Forde KA, Al-Naamani N, Krok KL, Patel M, Bartoli CR, Doyle M, Moutchia J, Lin G, Oh JK, Mottram CD, Scanlon PD, Fallon MB. Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis. Eur Respir J. 2022 08; 60(2). PMID: 34949701.
      View in: PubMed
    9. DuBrock HM, Del Valle KT, Krowka MJ. Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception. Liver Transpl. 2022 07; 28(7):1224-1230. PMID: 35106916.
      View in: PubMed
    10. Aragon Pinto C, Iyer V, Almodallal YA, Albitar H, Dubrock H, Cajigas H, Heimbach JK, Rosen CB, Watt K, Taner T, Nyberg S, Vargas H, Cartin-Ceba R, Keaveny AP, Krowka M, Gallo de Moraes A. ICU and Hospital Outcomes in Patients with Hepatopulmonary Syndrome Undergoing Liver Transplantation. Lung. 2022 02; 200(1):5-10. PMID: 35013756.
      View in: PubMed
    11. Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension. Transplantation. 2021 10 01; 105(10):2283-2290. PMID: 33065725.
      View in: PubMed
    12. Aragon Pinto C, Iyer VN, Albitar HAH, Anderson A, Cajigas H, Simonetto DA, Krowka MJ, DuBrock HM, Gallo de Moraes A. Outcomes of liver transplantation in patients with hepatopulmonary syndrome in the pre and post-MELD eras: A systematic review. Respir Med Res. 2021 Nov; 80:100852. PMID: 34418867.
      View in: PubMed
    13. Boike JR, Thornburg BG, Asrani SK, Fallon MB, Fortune BE, Izzy MJ, Verna EC, Abraldes JG, Allegretti AS, Bajaj JS, Biggins SW, Darcy MD, Farr MA, Farsad K, Garcia-Tsao G, Hall SA, Jadlowiec CC, Krowka MJ, Laberge J, Lee EW, Mulligan DC, Nadim MK, Northup PG, Salem R, Shatzel JJ, Shaw CJ, Simonetto DA, Susman J, Kolli KP, VanWagner LB. North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension. Clin Gastroenterol Hepatol. 2022 08; 20(8):1636-1662.e36. PMID: 34274511.
      View in: PubMed
    14. Abu Rmilah A, Fencl R, Watt K, Krowka M, Wiesner R, Murray D, Nyberg S, Leise M. Association of a 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. Transplantation. 2021 07 01; 105(7):1576-1584. PMID: 32732616.
      View in: PubMed
    15. DuBrock HM, Burger CD, Bartolome SD, Feldman JP, Ivy DD, Rosenzweig EB, Sager JS, Presberg KW, Mathai SC, Lammi MR, Klinger JR, Eggert M, De Marco T, Elwing JM, Badesch D, Bull TM, Cadaret LM, Ramani G, Thenappan T, Ford HJ, Al-Naamani N, Simon MA, Mazimba S, Runo JR, Chakinala M, Horn EM, Ryan JJ, Frantz RP, Krowka MJ. Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry. Pulm Circ. 2021 Jul-Sep; 11(3):20458940211020913. PMID: 34158918.
      View in: PubMed
    16. Murray JD, Willrich MA, Krowka MJ, Bobr A, Murray DL, Halling KC, Graham RP, Snyder MR. Liquid Chromatography-Tandem Mass Spectrometry-Based a1-Antitrypsin (AAT) Testing. Am J Clin Pathol. 2021 03 15; 155(4):547-552. PMID: 33083828.
      View in: PubMed
    17. Bohman JK, Findlay JY, Krowka MJ. ECMO and POPH: More Help for the Right Heart. Liver Transpl. 2021 05; 27(5):627-628. PMID: 32916765.
      View in: PubMed
    18. Hasan Albitar HA, Van Houten H, Sangaralingham LR, Knoedler M, Almodallal Y, Alkurashi AK, De Moraes AG, Cajigas H, DuBrock H, Warad D, Demirel N, Krowka M, Brinjikji W, Iyer VN. Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database. Mayo Clin Proc Innov Qual Outcomes. 2021 Feb; 5(1):55-64. PMID: 33718784.
      View in: PubMed
    19. DuBrock HM, Runo JR, Sadd CJ, Burger CD, Cartin-Ceba R, Rosen CB, Taner T, Nyberg SL, Heimbach JK, Findlay JY, Krowka MJ. Outcomes of Liver Transplantation in Treated Portopulmonary Hypertension Patients With a Mean Pulmonary Arterial Pressure =35 mm?Hg. Transplant Direct. 2020 Dec; 6(12):e630. PMID: 33204828.
      View in: PubMed
    20. DuBrock HM, Krowka MJ. The Myths and Realities of Portopulmonary Hypertension. Hepatology. 2020 10; 72(4):1455-1460. PMID: 32515501.
      View in: PubMed
    21. DuBrock HM, Krowka MJ. Bubble Trouble in COVID-19. Am J Respir Crit Care Med. 2020 10 01; 202(7):926-928. PMID: 32822239.
      View in: PubMed
    22. Al-Naamani N, Krowka MJ, Forde KA, Krok KL, Feng R, Heresi GA, Dweik RA, Bartolome S, Bull TM, Roberts KE, Austin ED, Hemnes AR, Patel MJ, Oh JK, Lin G, Doyle MF, Denver N, Andrew R, MacLean MR, Fallon MB, Kawut SM. Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2). Hepatology. 2021 02; 73(2):726-737. PMID: 32407592.
      View in: PubMed
    23. DuBrock HM, Cartin-Ceba R, Channick RN, Kawut SM, Krowka MJ. Sex Differences in Portopulmonary Hypertension. Chest. 2021 01; 159(1):328-336. PMID: 32798521.
      View in: PubMed
    24. Albitar HAH, Almodallal Y, Gallo De Moraes A, O'Brien E, Choby GW, Pruthi RK, Stokken JK, Kamath PS, Cajigas HR, DuBrock HM, Krowka MJ, Iyer VN. Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance Therapy. Mayo Clin Proc. 2020 08; 95(8):1604-1612. PMID: 32753135.
      View in: PubMed
    25. DuBrock HM, Krowka MJ, Krok K, Forde K, Mottram C, Scanlon P, Al-Naamani N, Patel M, McCormick A, Fallon MB, Kawut SM. Prevalence and Impact of Restrictive Lung Disease in Liver Transplant Candidates. Liver Transpl. 2020 08; 26(8):989-999. PMID: 32394590.
      View in: PubMed
    26. Rochon ER, Krowka MJ, Bartolome S, Heresi GA, Bull T, Roberts K, Hemnes A, Forde KA, Krok KL, Patel M, Lin G, McNeil M, Al-Naamani N, Roman BL, Yu PB, Fallon MB, Gladwin MT, Kawut SM. BMP9/10 in Pulmonary Vascular Complications of Liver Disease. Am J Respir Crit Care Med. 2020 06 15; 201(12):1575-1578. PMID: 32083953.
      View in: PubMed
    27. Krowka M, Cottreel E, Hoeper MM, Kim NH, Martin N, Sitbon O, Bosch J. Macitentan Improves Risk Categorization for Liver Transplant Mortality in Patients With Portopulmonary Hypertension: A PORTICO Study Post Hoc Analysis. Liver Transpl. 2020 07; 26(7):935-940. PMID: 32150762.
      View in: PubMed
    28. Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension: The Pulmonary Vascular Enigmas of Liver Disease. Clin Liver Dis (Hoboken). 2020 Feb; 15(Suppl 1):S13-S24. PMID: 32140210.
      View in: PubMed
    29. Preston IR, Burger CD, Bartolome S, Safdar Z, Krowka M, Sood N, Ford HJ, Battarjee WF, Chakinala MM, Gomberg-Maitland M, Hill NS. Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial. J Heart Lung Transplant. 2020 05; 39(5):464-472. PMID: 32008947.
      View in: PubMed
    30. Anand V, Frantz RP, DuBrock H, Kane GC, Krowka M, Yanagisawa R, Sandhu GS. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience. Mayo Clin Proc Innov Qual Outcomes. 2019 Sep; 3(3):311-318. PMID: 31485569.
      View in: PubMed
    31. Cartin-Ceba R, Krowka MJ. Pulmonary Complications of Portal Hypertension. Clin Liver Dis. 2019 11; 23(4):683-711. PMID: 31563218.
      View in: PubMed
    32. Iyer VN, Saberi B, Heimbach JK, Larson JJ, Raghavaiah S, Ditah I, Swanson K, Kamath PS, Watt KD, Taner T, Krowka MJ, Leise MD. Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States. Transplantation. 2019 07; 103(7):1418-1424. PMID: 30335701.
      View in: PubMed
    33. Sitbon O, Bosch J, Cottreel E, Csonka D, de Groote P, Hoeper MM, Kim NH, Martin N, Savale L, Krowka M. Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial. Lancet Respir Med. 2019 07; 7(7):594-604. PMID: 31178422.
      View in: PubMed
    34. Kawut SM, Ellenberg SS, Krowka MJ, Goldberg D, Vargas H, Koch D, Sharkoski T, Al-Naamani N, Fox A, Brown R, Levitsky J, Oh JK, Lin G, Song N, Mottram C, Doyle MF, Kaplan DE, Gupta S, Fallon MB. Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Liver Transpl. 2019 08; 25(8):1155-1164. PMID: 30816637.
      View in: PubMed
    35. DuBrock HM, Salgia RJ, Sussman NL, Bartolome SD, Kadry Z, Mulligan DC, Jenkins S, Lackore K, Channick RN, Kawut SM, Krowka MJ. Portopulmonary Hypertension: A Survey of Practice Patterns and Provider Attitudes. Transplant Direct. 2019 Jun; 5(6):e456. PMID: 31321292.
      View in: PubMed
    36. Krowka MJ. Treatment of Portopulmonary Hypertension With Macitentan in Patients With Cirrhosis. Gastroenterol Hepatol (N Y). 2019 Feb; 15(2):108-110. PMID: 31011305.
      View in: PubMed
    37. Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019 01; 53(1). PMID: 30545968.
      View in: PubMed
    38. AbuHalimeh B, Krowka MJ, Tonelli AR. Treatment Barriers in Portopulmonary Hypertension. Hepatology. 2019 01; 69(1):431-443. PMID: 30063259.
      View in: PubMed
    39. Forde KA, Fallon MB, Krowka MJ, Sprys M, Goldberg DS, Krok KL, Patel M, Lin G, Oh JK, Mottram CD, Scanlon PD, Kawut SM. Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation. Hepatology. 2019 01; 69(1):270-281. PMID: 30070715.
      View in: PubMed
    40. Fuhrmann V, Krowka M. Hepatopulmonary syndrome. J Hepatol. 2018 09; 69(3):744-745. PMID: 29960651.
      View in: PubMed
    41. Rodr?guez-Roisin R, Krowka MJ, Agust? A. Hepatopulmonary Disorders: Gas Exchange and Vascular Manifestations in Chronic Liver Disease. Compr Physiol. 2018 03 25; 8(2):711-729. PMID: 29687908.
      View in: PubMed
    42. Cartin-Ceba R, Halank M, Ghofrani HA, Humbert M, Mattson J, Fritsch A, Krowka M. Riociguat treatment for portopulmonary hypertension: a subgroup analysis from the PATENT-1/-2 studies. Pulm Circ. 2018 Apr-Jun; 8(2):2045894018769305. PMID: 29565224.
      View in: PubMed
    43. Gupta S, Krowka MJ. Hepatopulmonary syndrome. CMAJ. 2018 02 26; 190(8):E223. PMID: 29483331.
      View in: PubMed
    44. Iyer VN, Brinjikji W, Apala D, Pannu BS, Kotecha A, Leise MD, Kamath PS, Misra S, Lanzino G, Krowka MJ, Wood CP, Swanson KL. Impact of Age on Outcomes in Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia. Adv Hematol. 2018; 2018:4798425. PMID: 29610574.
      View in: PubMed
    45. Iyer VN, Apala DR, Pannu BS, Kotecha A, Brinjikji W, Leise MD, Kamath PS, Misra S, Begna KH, Cartin-Ceba R, DuBrock HM, Krowka MJ, O'Brien EK, Pruthi RK, Schroeder DR, Swanson KL. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding. Mayo Clin Proc. 2018 02; 93(2):155-166. PMID: 29395350.
      View in: PubMed
    46. DuBrock HM, Krowka MJ, Forde KA, Krok K, Patel M, Sharkoski T, Sprys M, Lin G, Oh JK, Mottram CD, Scanlon PD, Fallon MB, Kawut SM. Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant. Chest. 2018 02; 153(2):414-426. PMID: 28987478.
      View in: PubMed
    47. Segraves JM, Cartin-Ceba R, Leise MD, Krowka MJ. Relationship between portopulmonary hypertension and splenectomy: Mayo Clinic experience and review of published works. Hepatol Res. 2018 Feb; 48(3):E340-E346. PMID: 28667665.
      View in: PubMed
    48. DuBrock HM, Goldberg DS, Sussman NL, Bartolome SD, Kadry Z, Salgia RJ, Mulligan DC, Kremers WK, Kawut SM, Krowka MJ, Channick RN. Predictors of Waitlist Mortality in Portopulmonary Hypertension. Transplantation. 2017 07; 101(7):1609-1615. PMID: 28207639.
      View in: PubMed
    49. DeMartino ES, Cartin-Ceba R, Findlay JY, Heimbach JK, Krowka MJ. Frequency and Outcomes of Patients With Increased Mean Pulmonary Artery Pressure at the Time of Liver Transplantation. Transplantation. 2017 Jan; 101(1):101-106. PMID: 28009757.
      View in: PubMed
    50. DeMartino ES, Krowka MJ. Pulmonary Vascular Complications of Liver Disease. Int Anesthesiol Clin. 2017; 55(2):67-80. PMID: 28225533.
      View in: PubMed
    51. Krowka MJ, Heimbach JK. Portopulmonary hypertension and liver transplantation: A duo in question. Liver Transpl. 2016 12; 22(12):1633-1634. PMID: 27779823.
      View in: PubMed
    52. Iyer VN, Brinjikji W, Pannu BS, Apala DR, Lanzino G, Cloft HJ, Misra S, Krowka MJ, Wood CP, Swanson KL. Effect of Center Volume on Outcomes in Hospitalized Patients With Hereditary Hemorrhagic Telangiectasia. Mayo Clin Proc. 2016 Dec; 91(12):1753-1760. PMID: 27814895.
      View in: PubMed
    53. Brinjikji W, Wood CP, Lanzino G, Cloft HJ, Misra S, Kallmes DF, Kamath P, Pruthi RK, Krowka MJ, Swanson KL, Iyer VN. High Rates of Bleeding Complications among Hospitalized Patients with Hereditary Hemorrhagic Telangiectasia in the United States. Ann Am Thorac Soc. 2016 09; 13(9):1505-11. PMID: 27387823.
      View in: PubMed
    54. Krowka MJ, Fallon MB, Kawut SM, Fuhrmann V, Heimbach JK, Ramsay MA, Sitbon O, Sokol RJ. International Liver Transplant Society Practice Guidelines: Diagnosis and Management of Hepatopulmonary Syndrome and Portopulmonary Hypertension. Transplantation. 2016 Jul; 100(7):1440-52. PMID: 27326810.
      View in: PubMed
    55. Fussner LA, Krowka MJ. Current Approach to the Diagnosis and Management of Portopulmonary Hypertension. Curr Gastroenterol Rep. 2016 Jun; 18(6):29. PMID: 27098816.
      View in: PubMed
    56. Krowka MJ. Cardiopulmonary examination. Clin Liver Dis (Hoboken). 2016 May; 7(5):116-118. PMID: 31041044.
      View in: PubMed
    57. Rodriguez-Roisin R, Bartolome SD, Huchon G, Krowka MJ. Inflammatory bowel diseases, chronic liver diseases and the lung. Eur Respir J. 2016 Feb; 47(2):638-50. PMID: 26797027.
      View in: PubMed
    58. Lyle MA, Fenstad ER, McGoon MD, Frantz RP, Krowka MJ, Kane GC, Swanson KL. Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia. Chest. 2016 Feb; 149(2):362-371. PMID: 26204445.
      View in: PubMed
    59. Fussner LA, Iyer VN, Cartin-Ceba R, Lin G, Watt KD, Krowka MJ. Intrapulmonary vascular dilatations are common in portopulmonary hypertension and may be associated with decreased survival. Liver Transpl. 2015 Nov; 21(11):1355-64. PMID: 26077312.
      View in: PubMed
    60. DuBrock HM, Channick RN, Krowka MJ. What's new in the treatment of portopulmonary hypertension? Expert Rev Gastroenterol Hepatol. 2015 Jul; 9(7):983-92. PMID: 25882070.
      View in: PubMed
    61. Batra S, Machicao VI, Bynon JS, Mehta S, Tanikella R, Krowka MJ, Zacks S, Trotter J, Roberts KE, Brown RS, Kawut SM, Fallon MB. The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transpl. 2014 Jun; 20(6):705-12. PMID: 24659368.
      View in: PubMed
    62. Krowka MJ, Cartin-Ceba R. Portopulmonary hypertension: formidable dual threat versus hopeful dual therapy. Liver Transpl. 2014 Jun; 20(6):635-6. PMID: 24711442.
      View in: PubMed
    63. Singh S, Swanson KL, Hathcock MA, Kremers WK, Pallanch JF, Krowka MJ, Kamath PS. Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index. J Hepatol. 2014 Jul; 61(1):124-31. PMID: 24607625.
      View in: PubMed
    64. Cartin-Ceba R, Krowka MJ. Portopulmonary hypertension. Clin Liver Dis. 2014 May; 18(2):421-38. PMID: 24679504.
      View in: PubMed
    65. Cartin-Ceba R, Swanson KL, Krowka MJ. Response. Chest. 2014 Feb; 145(2):426-7. PMID: 24493537.
      View in: PubMed
    66. Dweik RA, Rounds S, Erzurum SC, Archer S, Fagan K, Hassoun PM, Hill NS, Humbert M, Kawut SM, Krowka M, Michelakis E, Morrell NW, Stenmark K, Tuder RM, Newman J. An official American Thoracic Society Statement: pulmonary hypertension phenotypes. Am J Respir Crit Care Med. 2014 Feb 01; 189(3):345-55. PMID: 24484330.
      View in: PubMed
    67. Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ. Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency?related cirrhosis. Liver Transpl. 2013 Dec; 19(12):1370-6. PMID: 24019185.
      View in: PubMed
    68. Cartin-Ceba R, Swanson KL, Krowka MJ. Pulmonary arteriovenous malformations. Chest. 2013 Sep; 144(3):1033-1044. PMID: 24008954.
      View in: PubMed
    69. Iyer VN, Swanson KL, Krowka MJ. Survival benefits of liver transplant in severe hepatopulmonary syndrome. Am J Respir Crit Care Med. 2013 Aug 15; 188(4):514. PMID: 23947524.
      View in: PubMed
    70. Porres-Aguilar M, Duarte-Rojo A, Krowka MJ. Transthoracic echocardiography screening for the detection of portopulmonary hypertension: a work in progress. Liver Transpl. 2013 Jun; 19(6):573-4. PMID: 23716426.
      View in: PubMed
    71. Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol. 2013 Aug; 59(2):367-74. PMID: 23557870.
      View in: PubMed
    72. Iyer VN, Swanson KL, Cartin-Ceba R, Dierkhising RA, Rosen CB, Heimbach JK, Wiesner RH, Krowka MJ. Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology. 2013 Jun; 57(6):2427-35. PMID: 22996424.
      View in: PubMed
    73. Patel SM, Sekiguchi H, Reynolds JP, Krowka MJ. Pulmonary alveolar proteinosis. Can Respir J. 2012 Jul-Aug; 19(4):243-5. PMID: 22891182.
      View in: PubMed
    74. Rahaghi FF, Sandhaus RA, Brantly ML, Rouhani F, Campos MA, Strange C, Hogarth DK, Eden E, Stocks JM, Krowka MJ, Stoller JK. The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction. COPD. 2012 Aug; 9(4):352-8. PMID: 22506682.
      View in: PubMed
    75. Krowka MJ. Portopulmonary hypertension. Semin Respir Crit Care Med. 2012 Feb; 33(1):17-25. PMID: 22447257.
      View in: PubMed
    76. Krowka MJ. Management of pulmonary complications in pretransplant patients. Clin Liver Dis. 2011 Nov; 15(4):765-77. PMID: 22032528.
      View in: PubMed
    77. Krowka MJ, Miller DP, Barst RJ, Taichman D, Dweik RA, Badesch DB, McGoon MD. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest. 2012 Apr; 141(4):906-915. PMID: 21778257.
      View in: PubMed
    78. Talwalkar JA, Swanson KL, Krowka MJ, Andrews JC, Kamath PS. Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment. Gastroenterology. 2011 Nov; 141(5):1673-9. PMID: 21723219.
      View in: PubMed
    79. Krowka MJ. Hepatopulmonary syndrome: monitoring at your fingertip. Dig Dis Sci. 2011 Jun; 56(6):1599-600. PMID: 21448697.
      View in: PubMed
    80. Li Y, Krowka MJ, Qi Y, Katzmann JA, Song Y, Li Y, Mandrekar SJ, Yang P. Alpha1-antitrypsin deficiency carriers, serum alpha 1-antitrypsin concentration, and non-small cell lung cancer survival. J Thorac Oncol. 2011 Feb; 6(2):291-5. PMID: 21173712.
      View in: PubMed
    81. Cartin-Ceba R, Swanson K, Iyer V, Wiesner RH, Krowka MJ. Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest. 2011 Jan; 139(1):109-14. PMID: 20705798.
      View in: PubMed
    82. Hackbarth JS, Tostrud LJ, Rumilla KM, Krowka MJ, Snyder MR. Discordant alpha-1 antitrypsin phenotype and genotype results in a liver transplant patient. Clin Chim Acta. 2010 Aug 05; 411(15-16):1146-8. PMID: 20362565.
      View in: PubMed
    83. Roberts KE, Kawut SM, Krowka MJ, Brown RS, Trotter JF, Shah V, Peter I, Tighiouart H, Mitra N, Handorf E, Knowles JA, Zacks S, Fallon MB. Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease. Gastroenterology. 2010 Jul; 139(1):130-9.e24. PMID: 20346360.
      View in: PubMed
    84. Tanikella R, Kawut SM, Brown RS, Krowka MJ, Reinen J, Dinasarapu CR, Trotter JF, Roberts KE, Mohd MA, Arnett DK, Fallon MB. Health-related quality of life and survival in liver transplant candidates. Liver Transpl. 2010 Feb; 16(2):238-45. PMID: 20104497.
      View in: PubMed
    85. Misselt AJ, Krowka MJ, Misra S. Successful coil embolization of mediastinal bronchial artery aneurysm. J Vasc Interv Radiol. 2010 Feb; 21(2):295-6. PMID: 20123213.
      View in: PubMed
    86. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009 Jun 30; 54(1 Suppl):S43-S54. PMID: 19555858.
      View in: PubMed
    87. Peng T, Zamanian R, Krowka MJ, Benza RL, Roberts KE, Taichman DB, Rybak D, Trotter JF, Brown RS, Fallon MB, Kawut SM. Plasma levels of S100A4 in portopulmonary hypertension. Biomarkers. 2009 May; 14(3):156-60. PMID: 19399660.
      View in: PubMed
    88. Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Kawut SM. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med. 2009 May 01; 179(9):835-42. PMID: 19218192.
      View in: PubMed
    89. Roberts KE, Fallon MB, Krowka MJ, Benza RL, Knowles JA, Badesch DB, Brown RS, Taichman DB, Trotter J, Zacks S, Horn EM, Kawut SM. Serotonin transporter polymorphisms in patients with portopulmonary hypertension. Chest. 2009 Jun; 135(6):1470-1475. PMID: 19141529.
      View in: PubMed
    90. Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation. 2008 Nov 27; 86(10):1384-8. PMID: 19034007.
      View in: PubMed
    91. Iqbal CW, Krowka MJ, Pham TH, Freese DK, El Youssef M, Ishitani MB. Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease. J Pediatr Surg. 2008 Oct; 43(10):1813-20. PMID: 18926213.
      View in: PubMed
    92. Porres-Aguilar M, Zuckerman MJ, Figueroa-Casas JB, Krowka MJ. Portopulmonary hypertension: state of the art. Ann Hepatol. 2008 Oct-Dec; 7(4):321-30. PMID: 19034231.
      View in: PubMed
    93. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008 Nov; 8(11):2445-53. PMID: 18782292.
      View in: PubMed
    94. Rybak D, Fallon MB, Krowka MJ, Brown RS, Reinen J, Stadheim L, Faulk D, Nielsen C, Al-Naamani N, Roberts K, Zacks S, Perry T, Trotter J, Kawut SM. Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation. Liver Transpl. 2008 Sep; 14(9):1357-65. PMID: 18756494.
      View in: PubMed
    95. Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S, Kaplowitz N, Brown RS, Fallon MB. Clinical risk factors for portopulmonary hypertension. Hepatology. 2008 Jul; 48(1):196-203. PMID: 18537192.
      View in: PubMed
    96. Fallon MB, Krowka MJ, Brown RS, Trotter JF, Zacks S, Roberts KE, Shah VH, Kaplowitz N, Forman L, Wille K, Kawut SM. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology. 2008 Oct; 135(4):1168-75. PMID: 18644373.
      View in: PubMed
    97. Rodr?guez-Roisin R, Krowka MJ. Hepatopulmonary syndrome--a liver-induced lung vascular disorder. N Engl J Med. 2008 May 29; 358(22):2378-87. PMID: 18509123.
      View in: PubMed
    98. Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, Thibodeau SN, Katzmann JA, Allen MS, Midthun DE, Marks RS, de Andrade M. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med. 2008 May 26; 168(10):1097-103. PMID: 18504338.
      View in: PubMed
    99. Swanson KL, Utz JP, Krowka MJ. Doppler echocardiography-right heart catheterization relationships in patients with idiopathic pulmonary fibrosis and suspected pulmonary hypertension. Med Sci Monit. 2008 Apr; 14(4):CR177-82. PMID: 18376344.
      View in: PubMed
    100. Krowka MJ, Fallon MB. Liver transplantation for hepatopulmonary syndrome (HPS): what is the MESSAGE? Am J Transplant. 2008 May; 8(5):911-2. PMID: 18325079.
      View in: PubMed
    101. Swanson KL, Krowka MJ. Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleve Clin J Med. 2008 Feb; 75(2):121-2, 125-30, 133 passim. PMID: 18290356.
      View in: PubMed
    102. Golbin JM, Krowka MJ. Portopulmonary hypertension. Clin Chest Med. 2007 Mar; 28(1):203-18, ix. PMID: 17338936.
      View in: PubMed
    103. Ryu JH, Krowka MJ, Pellikka PA, Swanson KL, McGoon MD. Pulmonary hypertension in patients with interstitial lung diseases. Mayo Clin Proc. 2007 Mar; 82(3):342-50. PMID: 17352370.
      View in: PubMed
    104. Fallon MB, Mulligan DC, Gish RG, Krowka MJ. Model for end-stage liver disease (MELD) exception for hepatopulmonary syndrome. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S105-7. PMID: 17123282.
      View in: PubMed
    105. Krowka MJ, Fallon MB, Mulligan DC, Gish RG. Model for end-stage liver disease (MELD) exception for portopulmonary hypertension. Liver Transpl. 2006 Dec; 12(12 Suppl 3):S114-6. PMID: 17123283.
      View in: PubMed
    106. Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology. 2006 Dec; 44(6):1502-10. PMID: 17133488.
      View in: PubMed
    107. Krowka MJ, Swanson KL. How should we treat portopulmonary hypertension? Eur Respir J. 2006 Sep; 28(3):466-7. PMID: 16946090.
      View in: PubMed
    108. Krowka MJ. Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis. 2006 Aug; 26(3):265-72. PMID: 16850376.
      View in: PubMed
    109. Parambil JG, Gersh BJ, Knight MZ, Krowka MJ, Ryu JH. Bronchogenic cyst causing atrial fibrillation by impinging the right inferior pulmonary vein. Am J Med Sci. 2006 Jun; 331(6):336-8. PMID: 16775444.
      View in: PubMed
    110. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest. 2005 Dec; 128(6 Suppl):616S-617S. PMID: 16373870.
      View in: PubMed
    111. Krowka MJ. Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation. Clin Chest Med. 2005 Dec; 26(4):587-97, vi. PMID: 16263398.
      View in: PubMed
    112. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest. 2005 Oct; 128(4):2393-9. PMID: 16236900.
      View in: PubMed
    113. Shapiro BP, Sprung J, Scott K, Arendt K, Krowka MJ, Afessa B. Cardiovascular collapse induced by position-dependent pulmonary vein occlusion in a patient with fibrosing mediastinitis. Anesthesiology. 2005 Sep; 103(3):661-3. PMID: 16129994.
      View in: PubMed
    114. Krowka MJ. Portopulmonary hypertension and the issue of survival. Liver Transpl. 2005 Sep; 11(9):1026-7. PMID: 16123957.
      View in: PubMed
    115. Yang P, Bamlet WR, Sun Z, Ebbert JO, Aubry MC, Krowka MJ, Taylor WR, Marks RS, Deschamps C, Swensen SJ, Wieben ED, Cunningham JM, Melton LJ, de Andrade M. Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk. Chest. 2005 Jul; 128(1):445-52. PMID: 16002971.
      View in: PubMed
    116. Krowka MJ. Many faces of portopulmonary hypertension. J Pediatr. 2005 Jul; 147(1):3-4. PMID: 16027682.
      View in: PubMed
    117. Rodr?quez-Roisin R, Krowka MJ, Herv? P, Fallon MB. Highlights of the ERS Task Force on pulmonary-hepatic vascular disorders (PHD). J Hepatol. 2005 Jun; 42(6):924-7. PMID: 15973780.
      View in: PubMed
    118. Swanson KL, Wiesner RH, Krowka MJ. Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology. 2005 May; 41(5):1122-9. PMID: 15828054.
      View in: PubMed
    119. Krowka MJ, Plevak D. The distinct concepts and implications of hepatopulmonary syndrome and portopulmonary hypertension. Crit Care Med. 2005 Feb; 33(2):470. PMID: 15699879.
      View in: PubMed
    120. Rodr?guez-Roisin R, Krowka MJ, Herv? P, Fallon MB. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J. 2004 Nov; 24(5):861-80. PMID: 15516683.
      View in: PubMed
    121. Chaowalit N, Pellikka PA, Decker PA, Aubry MC, Krowka MJ, Ryu JH, Vassallo R. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc. 2004 Oct; 79(10):1269-75. PMID: 15473409.
      View in: PubMed
    122. Nadrous HF, Krowka MJ, Myers JL, Allen MS, Sabri AN. Tracheal myxoma: a rare benign tracheal tumor. Mayo Clin Proc. 2004 Jul; 79(7):931-3. PMID: 15244393.
      View in: PubMed
    123. Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2004 Jun 16; 43(12 Suppl S):40S-47S. PMID: 15194177.
      View in: PubMed
    124. Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet. 2004 May 01; 363(9419):1461-8. PMID: 15121411.
      View in: PubMed
    125. Nadrous HF, Krowka MJ, McClure RF, Tefferi A, Lim KG. Agnogenic myeloid metaplasia with pleural extramedullary leukemic transformation. Leuk Lymphoma. 2004 Apr; 45(4):815-8. PMID: 15160962.
      View in: PubMed
    126. Yen KT, Lee AS, Krowka MJ, Burger CD. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment. Clin Chest Med. 2004 Mar; 25(1):189-201. PMID: 15062610.
      View in: PubMed
    127. Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M, Marotta P, Uemoto S, Stoffel MP, Benson JT. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004 Feb; 10(2):174-82. PMID: 14762853.
      View in: PubMed
    128. Krowka MJ. Portopulmonary hypertension: diagnostic advances and caveats. Liver Transpl. 2003 Dec; 9(12):1336-7. PMID: 14625836.
      View in: PubMed
    129. Arguedas MR, Abrams GA, Krowka MJ, Fallon MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology. 2003 Jan; 37(1):192-7. PMID: 12500204.
      View in: PubMed
    130. Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension. Curr Treat Options Cardiovasc Med. 2002 Jun; 4(3):267-273. PMID: 12003725.
      View in: PubMed
    131. Krowka MJ. Hepatopulmonary Syndrome and Portopulmonary Hypertension. Curr Treat Options Gastroenterol. 2001 Dec; 4(6):539-545. PMID: 11696280.
      View in: PubMed
    132. Dingli D, Utz JP, Krowka MJ, Oberg AL, Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest. 2001 Sep; 120(3):801-8. PMID: 11555513.
      View in: PubMed
    133. Krowka MJ. Hepatopulmonary syndrome and extrahepatic vascular abnormalities. Liver Transpl. 2001 Jul; 7(7):656-7. PMID: 11460237.
      View in: PubMed
    134. Krowka MJ. Caveats concerning hepatopulmonary syndrome. J Hepatol. 2001 May; 34(5):756-8. PMID: 11434623.
      View in: PubMed
    135. Krowka MJ, Wiseman GA, Burnett OL, Spivey JR, Therneau T, Porayko MK, Wiesner RH. Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. Chest. 2000 Sep; 118(3):615-24. PMID: 10988181.
      View in: PubMed
    136. Kim WR, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP, Wiesner RH. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 2000 Jul; 6(4):453-8. PMID: 10915168.
      View in: PubMed
    137. Krowka MJ. Hepatopulmonary syndrome: recent literature (1997 to 1999) and implications for liver transplantation. Liver Transpl. 2000 Jul; 6(4 Suppl 1):S31-5. PMID: 10915189.
      View in: PubMed
    138. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000 Jul; 6(4):443-50. PMID: 10915166.
      View in: PubMed
    139. Krowka MJ. Pulmonary hypertension: diagnostics and therapeutics. Mayo Clin Proc. 2000 Jun; 75(6):625-30. PMID: 10852424.
      View in: PubMed
    140. Krowka MJ, Edwards WD. A spectrum of pulmonary vascular pathology in portopulmonary hypertension. Liver Transpl. 2000 Mar; 6(2):241-2. PMID: 10719028.
      View in: PubMed
    141. Krowka MJ. Hepatopulmonary syndromes. Gut. 2000 Jan; 46(1):1-4. PMID: 10601042.
      View in: PubMed
    142. Findlay JY, Harrison BA, Plevak DJ, Krowka MJ. Inhaled nitric oxide reduces pulmonary artery pressures in portopulmonary hypertension. Liver Transpl Surg. 1999 Sep; 5(5):381-7. PMID: 10477839.
      View in: PubMed
    143. Findlay JY, Plevak DJ, Krowka MJ, Sack EM, Porayko MK. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg. 1999 Sep; 5(5):362-5. PMID: 10477835.
      View in: PubMed
    144. Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Wiesner RH. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology. 1999 Sep; 30(3):641-8. PMID: 10462369.
      View in: PubMed
    145. Krowka MJ, Wiseman GA, Steers JL, Wiesner RH. Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation. Liver Transpl Surg. 1999 Sep; 5(5):451-3. PMID: 10477847.
      View in: PubMed
    146. Lazaridis KN, Frank JW, Krowka MJ, Kamath PS. Hepatic hydrothorax: pathogenesis, diagnosis, and management. Am J Med. 1999 Sep; 107(3):262-7. PMID: 10492320.
      View in: PubMed
    147. Yang P, Wentzlaff KA, Katzmann JA, Marks RS, Allen MS, Lesnick TG, Lindor NM, Myers JL, Wiegert E, Midthun DE, Thibodeau SN, Krowka MJ. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev. 1999 May; 8(5):461-5. PMID: 10350443.
      View in: PubMed
    148. Abrams GA, Nanda NC, Dubovsky EV, Krowka MJ, Fallon MB. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology. 1998 Feb; 114(2):305-10. PMID: 9453490.
      View in: PubMed
    149. Krowka MJ, McGoon MD. Portopulmonary hypertension: the next step. Chest. 1997 Oct; 112(4):869-70. PMID: 9377945.
      View in: PubMed
    150. Mandall MS, Krowka MJ. Formation of a national database on pulmonary hypertension and hepatopulmonary syndrome in chronic liver disease. Anesthesiology. 1997 Aug; 87(2):450-1. PMID: 9286915.
      View in: PubMed
    151. Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology. 1997 May; 25(5):1282-4. PMID: 9141454.
      View in: PubMed
    152. Krowka MJ, Porayko MK, Plevak DJ, Pappas SC, Steers JL, Krom RA, Wiesner RH. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc. 1997 Jan; 72(1):44-53. PMID: 9005286.
      View in: PubMed
    153. Krowka MJ. Pathophysiology of arterial hypoxemia in advanced liver disease. Liver Transpl Surg. 1996 Jul; 2(4):308-12. PMID: 9346667.
      View in: PubMed
    154. Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, Cortese DA, Wiesner RH. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc. 1996 Jun; 71(6):543-51. PMID: 8642882.
      View in: PubMed
    155. Castro M, Krowka MJ. Hepatopulmonary syndrome. A pulmonary vascular complication of liver disease. Clin Chest Med. 1996 Mar; 17(1):35-48. PMID: 8665789.
      View in: PubMed
    156. Krowka MJ. Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C, and other hepatic problems. Clin Chest Med. 1996 Mar; 17(1):67-82. PMID: 8665791.
      View in: PubMed
    157. Krowka MJ. Hepatopulmonary syndrome: what are we learning from interventional radiology, liver transplantation, and other disorders? Gastroenterology. 1995 Sep; 109(3):1009-13. PMID: 7657087.
      View in: PubMed
    158. Poterucha JJ, Krowka MJ, Dickson ER, Cortese DA, Stanson AW, Krom RA. Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology. 1995 Jan; 21(1):96-100. PMID: 7806175.
      View in: PubMed
    159. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest. 1994 May; 105(5):1528-37. PMID: 8181347.
      View in: PubMed
    160. Rodriguez-Roisin R, Krowka MJ. Is severe arterial hypoxaemia due to hepatic disease an indication for liver transplantation? A new therapeutic approach. Eur Respir J. 1994 May; 7(5):839-42. PMID: 8050537.
      View in: PubMed
    161. Krowka MJ. Clinical management of hepatopulmonary syndrome. Semin Liver Dis. 1993 Nov; 13(4):414-22. PMID: 8303322.
      View in: PubMed
    162. Krowka MJ, Dickson ER, Cortese DA. Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest. 1993 Aug; 104(2):515-21. PMID: 8101797.
      View in: PubMed
    163. Afessa B, Gay PC, Plevak DJ, Swensen SJ, Patel HG, Krowka MJ. Pulmonary complications of orthotopic liver transplantation. Mayo Clin Proc. 1993 May; 68(5):427-34. PMID: 8479205.
      View in: PubMed
    164. Plevak D, Krowka M, Rettke S, Dunn W, Southorn P. Successful liver transplantation in patients with mild to moderate pulmonary hypertension. Transplant Proc. 1993 Apr; 25(2):1840. PMID: 8470192.
      View in: PubMed
    165. Krowka MJ. Hepatopulmonary syndrome. Transplant Proc. 1993 Apr; 25(2):1746-7. PMID: 8470149.
      View in: PubMed
    166. Krowka MJ, Dickson ER, Wiesner RH, Krom RA, Atkinson B, Cortese DA. A prospective study of pulmonary function and gas exchange following liver transplantation. Chest. 1992 Oct; 102(4):1161-6. PMID: 1395761.
      View in: PubMed
    167. Perrella MA, Edell ES, Krowka MJ, Cortese DA, Burnett JC. Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia. Am J Physiol. 1992 Jul; 263(1 Pt 2):R45-50. PMID: 1636793.
      View in: PubMed
    168. Krowka MJ. Lung function and the complications of bone marrow transplantation. Chest. 1992 May; 101(5):1186-7. PMID: 1582267.
      View in: PubMed
    169. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Chest. 1991 Jul; 100(1):296. PMID: 2060385.
      View in: PubMed
    170. Krowka MJ, Grambsch PM, Edell ES, Cortese DA, Dickson ER. Primary biliary cirrhosis: relation between hepatic function and pulmonary function in patients who never smoked. Hepatology. 1991 Jun; 13(6):1095-100. PMID: 2050328.
      View in: PubMed
    171. Krowka MJ, Cortese DA. Hepatopulmonary syndrome. Chest. 1990 Nov; 98(5):1053-4. PMID: 2225941.
      View in: PubMed
    172. Krowka MJ, Tajik AJ, Dickson ER, Wiesner RH, Cortese DA. Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest. 1990 May; 97(5):1165-70. PMID: 2331913.
      View in: PubMed
    173. Krowka MJ, Cortese DA. Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology. 1990 Jan; 11(1):138-42. PMID: 2403962.
      View in: PubMed
    174. Krowka MJ, Staats BA, Hoagland HC. A prospective study of airway reactivity before bone marrow transplantation. Mayo Clin Proc. 1990 Jan; 65(1):5-12. PMID: 2404165.
      View in: PubMed
    175. Krowka MJ, Cortese DA. Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med. 1989 Dec; 10(4):593-616. PMID: 2689067.
      View in: PubMed
    176. Edell ES, Cortese DA, Krowka MJ, Rehder K. Severe hypoxemia and liver disease. Am Rev Respir Dis. 1989 Dec; 140(6):1631-5. PMID: 2513764.
      View in: PubMed
    177. Krowka MJ, Enright PL, Rodarte JR, Hyatt RE. Effect of effort on measurement of forced expiratory volume in one second. Am Rev Respir Dis. 1987 Oct; 136(4):829-33. PMID: 3662235.
      View in: PubMed
    178. Krowka MJ, Pairolero PC, Trastek VF, Payne WS, Bernatz PE. Cardiac dysrhythmia following pneumonectomy. Clinical correlates and prognostic significance. Chest. 1987 Apr; 91(4):490-5. PMID: 3829739.
      View in: PubMed
    179. Krowka MJ, Cortese DA. Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. Mayo Clin Proc. 1987 Mar; 62(3):164-73. PMID: 3821178.
      View in: PubMed
    180. Krowka MJ, Cortese DA. Pulmonary aspects of chronic liver disease and liver transplantation. Mayo Clin Proc. 1985 Jun; 60(6):407-18. PMID: 3889511.
      View in: PubMed
    181. Krowka MJ, Rosenow EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest. 1985 Feb; 87(2):237-46. PMID: 2981658.
      View in: PubMed
    182. Krowka MJ, Breuer RI, Kehoe TJ. Azathioprine-associated pulmonary dysfunction. Chest. 1983 Apr; 83(4):696-8. PMID: 6831960.
      View in: PubMed
    183. Krowka MJ, Peak OC. Admission data: their use in health planning, legislative presentations, and premedical programs. J Med Educ. 1981 Sep; 56(9 Pt 1):777-9. PMID: 7277444.
      View in: PubMed
    184. Krowka MJ, Peck OC. Relating health planning concepts to medical students. J Med Educ. 1979 Dec; 54(12):946-7. PMID: 513098.
      View in: PubMed
    185. Krowka MJ, Peck OC. Continuing medical education as viewed by medical students. J Med Educ. 1979 Jan; 54(1):53-4. PMID: 762683.
      View in: PubMed
    186. Peck OC, Krowka MJ, May JR. Feedback from admission committees to applicant interviewers. J Med Educ. 1978 Aug; 53(8):680-1. PMID: 682162.
      View in: PubMed
    187. Krowka MJ, Schwartz JP. An empirical approach to projecting regional blood need. Transfusion. 1977 Sep-Oct; 17(5):479-83. PMID: 910265.
      View in: PubMed
    Krowka's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (432) concept(s)
    _
    Co-Authors Expand Description
    See all (8) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)